402 related articles for article (PubMed ID: 8637203)
1. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
Layfield LJ; Saria EA; Conlon DH; Kerns BJ
J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
[TBL] [Abstract][Full Text] [Related]
2. Image analysis for quantitation of estrogen receptor in formalin-fixed paraffin-embedded sections of breast carcinoma.
Baddoura FK; Cohen C; Unger ER; DeRose PB; Chenggis M
Mod Pathol; 1991 Jan; 4(1):91-5. PubMed ID: 1708502
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
Oyaizu T; Arita S; Hatano T; Tsubura A
J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay.
Wilbur DC; Willis J; Mooney RA; Fallon MA; Moynes R; di Sant'Agnese PA
Mod Pathol; 1992 Jan; 5(1):79-84. PubMed ID: 1371874
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
6. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
[TBL] [Abstract][Full Text] [Related]
7. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
[TBL] [Abstract][Full Text] [Related]
10. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma].
Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M
Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316
[TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of various biochemical and immunohistochemical methods for evaluating hormone receptors in breast carcinoma].
Gallo C; Orlassino R; Demarchi A; Vallero P; Vineis C
Pathologica; 2002 Aug; 94(4):176-80. PubMed ID: 12325415
[TBL] [Abstract][Full Text] [Related]
12. Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma.
Fisher ER; Anderson S; Dean S; Dabbs D; Fisher B; Siderits R; Pritchard J; Pereira T; Geyer C; Wolmark N
Cancer; 2005 Jan; 103(1):164-73. PubMed ID: 15565575
[TBL] [Abstract][Full Text] [Related]
13. Improvement of the quantification of estrogen and progesterone receptors in paraffin-embedded tumors by image analysis.
Esteban JM; Kandalaft PL; Mehta P; Odom-Maryon TL; Bacus S; Battifora H
Am J Clin Pathol; 1993 Jan; 99(1):32-8. PubMed ID: 8422013
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M
Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956
[TBL] [Abstract][Full Text] [Related]
16. Automated immunohistochemical assay for estrogen receptor status in breast cancer using monoclonal antibody CC4-5 on the Ventana ES.
Nichols GE; Frierson HF; Boyd JC; Hanigan MH
Am J Clin Pathol; 1996 Sep; 106(3):332-8. PubMed ID: 8816590
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor immunohistochemical quantitation compared with cytosolic assay: correlation with prognosis in breast cancer.
Lohmann C; Gibney E; Cotsonis G; Lawson D; Cohen C
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):49-53. PubMed ID: 11277415
[TBL] [Abstract][Full Text] [Related]
18. Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.
Andersen J
Acta Oncol; 1992; 31(6):611-27. PubMed ID: 1281648
[TBL] [Abstract][Full Text] [Related]
19. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
Calzada L; Salazar EL; Pedron Nuevo N
Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
[TBL] [Abstract][Full Text] [Related]
20. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
Alberts SR; Ingle JN; Roche PR; Cha SS; Wold LE; Farr GH; Krook JE; Wieand HS
Cancer; 1996 Aug; 78(4):764-72. PubMed ID: 8756370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
